Axa’s Northrop Grumman NOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-16,338
| Closed | -$8.17M | – | 710 |
|
|
2025
Q2 | $8.17M | Buy |
16,338
+15,309
| +1,488% | +$7.53M | 0.02% | 447 |
|
|
2025
Q1 | $527K | Hold |
1,029
| – | – | ﹤0.01% | 922 |
|
|
2024
Q4 | $483K | Sell |
1,029
-7
| -0.7% | -$3.52K | ﹤0.01% | 948 |
|
|
2024
Q3 | $547K | Sell |
1,036
-13
| -1% | -$6.37K | ﹤0.01% | 948 |
|
|
2024
Q2 | $457K | Sell |
1,049
-606
| -37% | -$277K | ﹤0.01% | 959 |
|
|
2024
Q1 | $792K | Buy |
1,655
+155
| +10% | +$71.4K | ﹤0.01% | 872 |
|
|
2023
Q4 | $702K | Sell |
1,500
-103
| -6% | -$48.3K | ﹤0.01% | 895 |
|
|
2023
Q3 | $706K | Buy |
1,603
+500
| +45% | +$220K | ﹤0.01% | 890 |
|
|
2023
Q2 | $503K | Sell |
1,103
-3,000
| -73% | -$1.36M | ﹤0.01% | 943 |
|
|
2023
Q1 | $1.89M | Sell |
4,103
-1
| -0% | -$464 | 0.01% | 778 |
|
|
2022
Q4 | $2.24M | Sell |
4,104
-411
| -9% | -$214K | 0.01% | 758 |
|
|
2022
Q3 | $2.12M | Buy |
4,515
+264
| +6% | +$126K | 0.01% | 750 |
|
|
2022
Q2 | $2.03M | Buy |
4,251
+63
| +2% | +$28.9K | 0.01% | 769 |
|
|
2022
Q1 | $1.87M | Buy |
4,188
+1,100
| +36% | +$454K | 0.01% | 835 |
|
|
2021
Q4 | $1.2M | Buy |
3,088
+600
| +24% | +$223K | ﹤0.01% | 927 |
|
|
2021
Q3 | $896K | Hold |
2,488
| – | – | ﹤0.01% | 984 |
|
|
2021
Q2 | $904K | Buy |
2,488
+68
| +3% | +$24.5K | ﹤0.01% | 1027 |
|
|
2021
Q1 | $783K | Buy |
2,420
+200
| +9% | +$60.3K | ﹤0.01% | 1017 |
|
|
2020
Q4 | $677K | Buy |
2,220
+7
| +0.3% | +$2.14K | ﹤0.01% | 1030 |
|
|
2020
Q3 | $699K | Buy |
2,213
+100
| +5% | +$32.6K | ﹤0.01% | 989 |
|
|
2020
Q2 | $650K | Buy |
+2,113
| New | +$693K | ﹤0.01% | 1020 |
|
|
2020
Q1 | – | Sell |
-1,013
| Closed | -$349K | – | 1229 |
|
|
2019
Q4 | $349K | Sell |
1,013
-400
| -28% | -$141K | ﹤0.01% | 1051 |
|
|
2019
Q3 | $529K | Buy |
1,413
+113
| +9% | +$40K | ﹤0.01% | 1086 |
|
|
2019
Q2 | $420K | Sell |
1,300
-755
| -37% | -$225K | ﹤0.01% | 1100 |
|
|
2019
Q1 | $554K | Buy |
2,055
+299
| +17% | +$81.6K | ﹤0.01% | 1089 |
|
|
2018
Q4 | $430K | Sell |
1,756
-111,410
| -98% | -$30.8M | ﹤0.01% | 1115 |
|
|
2018
Q3 | $35.9M | Sell |
113,166
-24,877
| -18% | -$7.58M | 0.13% | 205 |
|
|
2018
Q2 | $42.5M | Buy |
138,043
+1,692
| +1% | +$559K | 0.16% | 167 |
|
|
2018
Q1 | $47.6M | Sell |
136,351
-37,776
| -22% | -$12.7M | 0.19% | 144 |
|
|
2017
Q4 | $53.4M | Sell |
174,127
-6,277
| -3% | -$1.89M | 0.21% | 139 |
|
|
2017
Q3 | $51.9M | Hold |
180,404
| – | – | 0.22% | 131 |
|
|
2017
Q2 | $46.3M | Sell |
180,404
-14,798
| -8% | -$3.7M | 0.21% | 147 |
|
|
2017
Q1 | $46.4M | Sell |
195,202
-11,018
| -5% | -$2.62M | 0.21% | 144 |
|
|
2016
Q4 | $48M | Sell |
206,220
-2,500
| -1% | -$581K | 0.23% | 130 |
|
|
2016
Q3 | $44.7M | Buy |
208,720
+46,200
| +28% | +$10M | 0.2% | 153 |
|
|
2016
Q2 | $36.1M | Sell |
162,520
-40,835
| -20% | -$8.6M | 0.16% | 173 |
|
|
2016
Q1 | $40.2M | Sell |
203,355
-55,260
| -21% | -$10.4M | 0.18% | 159 |
|
|
2015
Q4 | $48.8M | Sell |
258,615
-84,451
| -25% | -$15.5M | 0.21% | 136 |
|
|
2015
Q3 | $56.9M | Sell |
343,066
-653,587
| -66% | -$110M | 0.23% | 115 |
|
|
2015
Q2 | $158M | Sell |
996,653
-215,952
| -18% | -$34.6M | 0.63% | 27 |
|
|
2015
Q1 | $195M | Sell |
1,212,605
-156,640
| -11% | -$25M | 0.8% | 14 |
|
|
2014
Q4 | $202M | Sell |
1,369,245
-85,800
| -6% | -$11.8M | 0.81% | 16 |
|
|
2014
Q3 | $192M | Sell |
1,455,045
-53,895
| -4% | -$6.8M | 0.82% | 15 |
|
|
2014
Q2 | $181M | Buy |
1,508,940
+13,840
| +0.9% | +$1.67M | 0.75% | 22 |
|
|
2014
Q1 | $184M | Buy |
1,495,100
+457,730
| +44% | +$54.2M | 0.8% | 19 |
|
|
2013
Q4 | $119M | Sell |
1,037,370
-61,498
| -6% | -$6.58M | 0.53% | 37 |
|
|
2013
Q3 | $105M | Sell |
1,098,868
-103,132
| -9% | -$9.53M | 0.52% | 42 |
|
|
2013
Q2 | $99.5M | Buy |
+1,202,000
| New | +$93.6M | 0.53% | 42 |
|
Other funds holding NOC
Axa's NOC Position: Q3 2025 in Review
Axa sold out of Northrop Grumman (NOC) in Q3 2025, closing a stake of 16,338 shares — an estimated $8.17M sold.
Axa first reported a position in NOC in Q2 2013 and held it in 48 quarters. The position peaked at $202M in Q4 2014. 1,714 funds tracked by Wall St. Rank hold NOC as of Q3 2025.
- Axa reported no remaining Northrop Grumman position as of Q3 2025 after selling out during the quarter.
- Axa sold 16,338 Northrop Grumman shares in Q3 2025, an estimated $8.17M.
- Axa first reported a position in Northrop Grumman in Q2 2013 and held it in 48 quarters.
- Axa's Northrop Grumman position peaked at $202M in Q4 2014.
- 1,714 funds tracked by Wall St. Rank held Northrop Grumman as of Q3 2025.
Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.